Abmining
Massive antibody mining, an unique platform for accelerating R&D timeline of therapeutic antibodies.
Proprietary Topo-Antibody® with global epitope coverage combines with digital immortalization facilitate accelerated timeline for the development of new antibody therapeutics.
If you are interested in Abmining project, please feel free to contact us for further discussion!
Recombinant protein as a Pan Fc Receptor Interacting molecule
Development of a high-affinity PD-L1 decoy protein as a therapeutic molecule.
a Non-Antibody Biologics engineered for Blocking of SARS-CoV-2 Binding to ACE2.